↓ Skip to main content

Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast Cancer

Overview of attention for article published in Frontiers in oncology, March 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
5 X users

Readers on

mendeley
49 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast Cancer
Published in
Frontiers in oncology, March 2020
DOI 10.3389/fonc.2020.00405
Pubmed ID
Authors

Chintan Shah, Young-Rock Hong, Rohit Bishnoi, Azka Ali, William Paul Skelton, Long H. Dang, Jinhai Huo, Nam H. Dang

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 16%
Student > Ph. D. Student 7 14%
Researcher 5 10%
Lecturer 3 6%
Student > Doctoral Student 2 4%
Other 6 12%
Unknown 18 37%
Readers by discipline Count As %
Medicine and Dentistry 9 18%
Biochemistry, Genetics and Molecular Biology 8 16%
Unspecified 2 4%
Immunology and Microbiology 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Other 5 10%
Unknown 21 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 November 2022.
All research outputs
#8,540,769
of 25,387,668 outputs
Outputs from Frontiers in oncology
#3,359
of 22,433 outputs
Outputs of similar age
#163,790
of 396,472 outputs
Outputs of similar age from Frontiers in oncology
#88
of 482 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,433 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 396,472 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 482 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.